Company: RVRC
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121070
Chunk: 190

Company: Revium Rx.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 190
---
31, 2022 |     |             | 127,203 |     |                  | 3 |     |            | 1,512 |     |             | (935   | ) |     |        |    580 |   |
| Issuance of shares           |     |             |  16,244 |     |                  | 1 |     |            | 1,593 |     |             | -      |   |     |        |  1,594 |   |
| Share based payment          |     |             |       - |     |                  | - |     |            |   205 |     |             | -      |   |     |        |    205 |   |
| Net loss for the period      |     |             |       - |     |                  | - |     |            |     - |     |             | (987   | ) |     |        |   (987 | ) |
| Balance at December 31, 2023 |     |             | 143,447 |     |                  | 4 |     |            | 3,310 |     |             | (1,922 | ) |     |        |  1,392 |   |
| Share based payment          |     |             |       - |     |                  | - |     |            |   710 |     |             | -      |   |     |        |    710 |   |
| Net loss for the period      |     |             |       - |     |                  | - |     |            |     - |     |             | (1,421 | ) |     |        | (1,421 | ) |
| Balance at July 23, 2024     |     |             | 143,447 |     |                  | 4 |     |            | 4,020 |     |             | (3,343 | ) |     |        |    681 |   |

| *) | less            
 than 1 thousand |

<div align='center'>F-5</div>

REVIUM RX.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

U.S. dollars in thousands (except share data)

|                                                |     | Successor     |            |     |               |    |     |                  |   |     |                  |   |     |            |        |     |                 |      |   |     |